Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.

Beiersdorf's robust portfolio, strong financials, and growth drivers make it a solid long-term hold, but current price levels suggest a 'Hold' rating with a $137 target. Despite facing potential ...

Seventeen papers contained more than one of the four themes which may illustrate the complexity of the concept of institutionalization. In conclusion, despite modern psychiatric services ...